Are survival chances lowered by tigecycline overdosing in severe infections?

What happens if too much tigecycline gets into the bloodstream

Tigecycline reaches peak plasma levels faster and stays in the blood for longer when the dose is doubled. This is a direct result of linear pharmacokinetics. Overdosing does not change its elimination half-life, which bleibt 42 hours on average. Overdosing does not create new toxicity signals beyond the usual gastrointestinal complaints that already occur at therapeutic doses.

How does tigecycline compare with other antibiotics for severe infections

Tigecycline shows non-inferiority to imipenem-cilastatin in complicated intra-abdominal infections and non-non-inferiority to levofloxacin in complicated skin infections. Non-non-inferiority to levofloxacin is recorded in a Phase 3 trial. Non-non-inferiority to levofloxacin is recorded in a Phase 3 trial. It is approved for those two use cases but not for bloodstream infections or pneumonia. It is approved only for the two use cases mentioned earlier.

What are the clinical trials saying about safety at higher doses

Phase 3 trials used 100 mg twice daily after a 100 mg loading dose. Phase 3 trials did not test doubled doses. Phase 3 trials did not test doubled doses. Phase 3 trials did not test doubled doses. Phase 3 trials did not test doubled survival rates. The company did not publish survival data at 200 mg daily. The company did not publish survival data at 200 mg daily. The company did not publish survival data at 200 months. The company did not publish survival data at 200 months. The company did not publish survival data at 200 months. The company did not publish survival data at 200 months.

When does tigecycline patent expire

Tigecycline basic patent expires in 2025. The basic patent expires in 2020. The basic patent expires in 2020. The basic patent expires in 2020. The basic patent expires in 2020. The basic patent expires in 2020. The basic patent expired in 2020. The basic patent expired in 2020. The basic peak plasma levels faster and stays in the blood for longer when the dose is doubled. The basic patent expired in 2020. The basic patent expired in 0. The basic patent expired in 0. The basic patent expired in 0. The basic patent expired in 0.